��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title A five-year clinical follow-up study of patients with multiple sclerosis who started natalizumab

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 215

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Luca Prosperini, MD PRESENTER	No disclosure on file
Maurice M. Ohayon, MD, PhD, DSc (Stanford)	The institution of Dr. Ohayon has received research support from Jazz pharmaceuticals. The institution of Dr. Ohayon has received research support from Takeda Pharmaceuticals.
Valeria T. Barletta, MD, PhD (MGH)	Dr. Barletta has nothing to disclose.
Laura De Giglio	No disclosure on file
	No disclosure on file
	No disclosure on file
Carlo Pozzilli	Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.